Management of connective tissue diseases associated intersti... : Current Opinion in
Rheumatology Management of connective tissue diseases associated interstitial lung …

Interstitial lung disease (ILD) commonly complicates the management of connective tissue
diseases (CTDs). Because the pulmonary specialist often is involved in the care of these …

The term connective tissue disease (CTD) encompasses multiple entities, whose common
characteristic is the immune-mediated injury of collagen affecting many organs, including …

The lung is frequently involved in connective tissue diseases (CTDs), although the
frequency of lung manifestations varies according to the type of CTD. Interstitial lung …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications associated
with connective tissue diseases (CTDs), resulting in significant morbidity and mortality …

Interstitial lung disease (ILD) occurs in 15% of patients with collagen vascular disease
(CVD), referred to as connective tissue disease (CTD). Despite advances in management …

Pulmonary complications are an important extra-articular feature of autoimmune rheumatic
diseases and a major cause of mortality. The underlying pathogenesis probably involves …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Interstitial lung disease (ILD) is commonly present in patients with an underlying connective
tissue disease (CTD), particularly those with systemic sclerosis, rheumatoid arthritis, and …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …